Parainfluenza Virus 2

ISO 9001 Quality Assurance Manufacturing | Print

No associated image currently available

Native Parainfluenza Virus 2

Product Type: Antigen
Specificity: Parainfluenza Virus 2

Quick Links:

Applications
Storage Information
Batch/Lot Specific Datasheets

Antibody Quality and Performance Guarantee

Unrivaled Technical Support

Product Code Applications Pack Size List Price Your Price Qty

List Price	Your Price
PIP016 Datasheet Datasheet SDS SDS	E	1 ml		Log in	Get Quote
	Log in

Native Parainfluenza Virus 2 contains a high concentration of virus and viral components. The preparation also contains some cellular material suspended in Tissue Culture Media.

Parainfluenza virus 2 is one of four serotypes of parainfluenza viruses in the paramoxyvirus family. Parainfluenza viruses are the second most common cause of lower respiratory tract infections in young children. Parainfluenza virus 2 causes upper and lower respiratory tract illnesses and croup.

Target Species: Viral
Product Form: Inactivated Parainfluenza virus 2 - liquid
Preparation: Parainfluenza virus 1, VP1 strain, cultured in Vero cells. Optimally infected monolayers are harvested, disrupted by sonication and subjected to low speed centrifugation. The clarified cell lysate is pooled with supernatant from the infected culture and concentrated using crossflow ultrafiltration with a 30,000 molecular cutoff. The antigen preparation is inactivated using gamma radiation.
Buffer Solution: Tissue Culture Media
Preservative Stabilisers: None present
Activity: This product has been rendered inactive by standard procedures. However this material should still be handled as infectious and should be disposed of appropriately.
Approx. Protein Concentrations: Current, batch-specific concentration 2.4 mg/ml
Regulatory: For research purposes only
Guarantee: 12 months from date of despatch

Store at -70^oC.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein.

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.

Application Name	Verified	Min Dilution	Max Dilution
ELISA

Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.

Instructions For Use: This product should be sonicated immediately before use to ensure the preparation is uniform. The product may be used in a variety of immunoassay formats or may be further purified to meet the requirements of a particular assay format.